The Nelson Report

Savara's potential new therapy for autoimmune PAP, MOLBREEVI, gets a powerful partner in PANTHERx Rare, promising a new era of comprehensive patient care.

With key studies now complete, Biofrontera's light-based therapy Ameluz could soon offer a new weapon against widespread actinic keratosis and stubborn acne.

Rani Therapeutics starts Phase 1 trials for an oral obesity drug, challenging the injectable market with a novel delivery system and a dual-action compound.

With its CEO stepping down, Lifeist Wellness tasks its CFO with a dual role, signaling a push for stability as it navigates a tough market.

With its $20M IPO, Buda Juice plans a national expansion. Its goal: make its cold-crafted, clean-label juices the new standard for fresh beverages.

Defense tech startup Vatn Systems acquires Crewless Marine, a strategic move to vertically integrate key sensor technology and accelerate its rise in naval warfare.

Cynomi hires ThreatLocker's former CRO Shane Deegan, signaling a major push to help MSPs turn cybersecurity from a cost center into a profit engine.

Navan CEO Ariel Cohen will pitch his growth strategy at the Needham conference, a key test for the travel tech firm amid stock declines and high hopes.

A new partnership gives NWS forecasters unprecedented views into weather blind spots, boosting warning capabilities for 130 million Americans.

From innovative liquid-cooled LCDs to premium laser TVs with Google TV, Formovie's latest projectors signal a major play for the entire home cinema market.

The new platform aims to end fragmented messaging in schools by centralizing email and SMS, promising to save educators time and deepen family engagement.

From tri-fold projectors for your EV to Roku TV integration, Aurzen's new devices at CES 2026 are pushing the boundaries of portable entertainment.

Forrester recognizes Teradata's vision and performance in data fabric, highlighting the critical role of autonomous AI in the future of enterprise data.

Nearing its 100th anniversary, global engineering firm Syska Hennessy unveils a new brand and a 10-year plan focused on tech and innovation.

Fintech firm VoPay establishes its global headquarters in Qatar, aiming to modernize finance in MENA and Asia while creating over 400 local tech jobs.

With quantum threats looming, BTQ Technologies adds a Wall Street veteran to its board, signaling a strategic move to build credibility with financial institutions.

With a key presentation looming, Star Therapeutics aims to showcase its universal hemostatic therapy, VGA039, for von Willebrand disease.

Formerly Cybin, Helus Pharma's Nasdaq launch marks a pivotal shift towards commercializing its breakthrough depression and anxiety drug pipeline.

New 2025 U-Haul data reveals a sustained migration to southern states like Texas and Florida, while California and New York see a continued exodus.

Facing its lowest donation levels in two decades, the Red Cross offers a Super Bowl trip to spur giving as hospitals risk rationing critical blood supplies.